ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	19/152	233/7206	3.66188310699e-07
ko04916	Melanogenesis	14/152	142/7206	1.48740354413e-06
ko04020	Calcium signaling pathway	19/152	265/7206	2.60158872577e-06
ko05200	Pathways in cancer	25/152	492/7206	4.99801873142e-05
ko04310	Wnt signaling pathway	13/152	181/7206	0.000107127434836
ko05230	Central carbon metabolism in cancer	7/152	81/7206	0.00152469005503
ko04925	Aldosterone synthesis and secretion	8/152	105/7206	0.0016132074288
ko04390	Hippo signaling pathway	11/152	188/7206	0.0020081478906
ko04713	Circadian entrainment	9/152	136/7206	0.00223624696986
ko04070	Phosphatidylinositol signaling system	8/152	112/7206	0.00243087231573
ko05217	Basal cell carcinoma	6/152	68/7206	0.00297544830792
ko04971	Gastric acid secretion	7/152	98/7206	0.00450706301117
ko05146	Amoebiasis	7/152	99/7206	0.00476617844088
ko04540	Gap junction	8/152	128/7206	0.00551194447231
ko04725	Cholinergic synapse	9/152	160/7206	0.0065677294251
ko04550	Signaling pathways regulating pluripotency of stem cells	9/152	165/7206	0.00798469780181
ko04745	Phototransduction - fly	4/152	38/7206	0.00804548386291
ko04015	Rap1 signaling pathway	13/152	278/7206	0.00809014099294
ko05224	Breast cancer	9/152	174/7206	0.0111098205839
ko05031	Amphetamine addiction	6/152	91/7206	0.0122162347953
ko04371	Apelin signaling pathway	9/152	177/7206	0.0123325774648
ko04921	Oxytocin signaling pathway	10/152	209/7206	0.0127286646791
ko04912	GnRH signaling pathway	7/152	122/7206	0.0143818718594
ko04750	Inflammatory mediator regulation of TRP channels	7/152	122/7206	0.0143818718594
ko05205	Proteoglycans in cancer	12/152	271/7206	0.0145819763929
ko04724	Glutamatergic synapse	8/152	152/7206	0.014822732256
ko04720	Long-term potentiation	6/152	99/7206	0.0179192348952
ko04350	TGF-beta signaling pathway	6/152	103/7206	0.0213627664388
ko04080	Neuroactive ligand-receptor interaction	16/152	423/7206	0.0215281351333
ko04370	VEGF signaling pathway	5/152	77/7206	0.0229022826697
ko04923	Regulation of lipolysis in adipocytes	5/152	77/7206	0.0229022826697
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/152	135/7206	0.0237444482068
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/152	79/7206	0.0252717800097
ko04512	ECM-receptor interaction	5/152	79/7206	0.0252717800097
ko05214	Glioma	5/152	79/7206	0.0252717800097
ko04726	Serotonergic synapse	7/152	137/7206	0.0254872312972
ko04740	Olfactory transduction	5/152	80/7206	0.0265134100857
ko04930	Type II diabetes mellitus	4/152	54/7206	0.0266286072939
ko04727	GABAergic synapse	6/152	110/7206	0.0284190496611
ko05032	Morphine addiction	6/152	110/7206	0.0284190496611
ko05212	Pancreatic cancer	5/152	83/7206	0.0304699113817
ko05210	Colorectal cancer	5/152	86/7206	0.034780065367
ko04924	Renin secretion	5/152	86/7206	0.034780065367
ko04510	Focal adhesion	10/152	240/7206	0.0356150140169
ko04911	Insulin secretion	6/152	117/7206	0.0368671586156
ko04072	Phospholipase D signaling pathway	9/152	197/7206	0.0373404964539
ko04662	B cell receptor signaling pathway	5/152	88/7206	0.0378533493647
ko04062	Chemokine signaling pathway	9/152	201/7206	0.0389611171131
ko04742	Taste transduction	4/152	61/7206	0.0392868815861
ko04670	Leukocyte transendothelial migration	7/152	151/7206	0.0401805497946
ko04270	Vascular smooth muscle contraction	7/152	154/7206	0.043925522245
ko04022	cGMP-PKG signaling pathway	9/152	216/7206	0.0480070587096
ko05145	Toxoplasmosis	6/152	126/7206	0.0498903798985
ko04970	Salivary secretion	5/152	95/7206	0.0498915331848